Skip to main content
. 2024 May 3;10(9):e30581. doi: 10.1016/j.heliyon.2024.e30581

Table 1.

Clinical descriptors of the derivation and validation cohorts at the baseline.

Alive at 3 Years (N = 492) Dead at 3 Years (N = 159) P
Demographics
 Male, % 225 (45.73) 81 (50.94) 0.292
 Age, years 68.91 (67.59–70.23) 75.21 (73.28–77.14) <0.001
 Hospitalization, days 8.86 (7.77–9.95) 13.15 (10.64–15.66) <0.001
 ICU, day 1.70 (1.24–2.16) 2.35 (1.51–3.19) 0.170
Comorbidities
 COPD, % 19 (3.86) 15 (9.43) 0.011
 DM, % 296 (60.16) 85 (53.46) 0.162
 MI, % 28 (5.69) 10 (6.29) 0.932
 CVA, % 46 (9.35) 28 (17.61) 0.007
 Cirrhosis, % 17 (3.46) 10 (6.29) 0.184
Biomarker
 NT-proBNP, mg/dl 15961.83 (14759.11–17164.56) 19741.25 (17562.53–21919.97) 0.003

COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; MI = myocardial infarction; CVA = cerebral vascular accident.

The values are the mean (confidence interval) or n (%).